These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 123336)

  • 21. The production of acidic polysaccharides by 5-bromodeoxyuridine-treated B16 mouse melanoma cells.
    Sato C; Kreider JW; Banks J; Garlick S; Davidson EA
    Cancer Res; 1975 Sep; 35(9):2532-9. PubMed ID: 1170945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromodeoxyuridine-induced changes in the transformed phenotype.
    Avdalovic N
    Ann N Y Acad Sci; 1980; 349():346-56. PubMed ID: 6939365
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
    Bizik J; Lizonová A; Stephens RW; Grófová M; Vaheri A
    Cell Regul; 1990 Nov; 1(12):895-905. PubMed ID: 1712633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirement of long progression time for the expression of neoplastic phenotypes following direct perturbation to specific region(s) of DNA of Syrian hamster embryo cells.
    Tsutsui T; Ts'o PO
    Cancer Res; 1986 Jul; 46(7):3533-7. PubMed ID: 3708584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of plasminogen activators formed by neoplastic human cell cultures.
    Rifkin DB; Loeb JN; Moore G; Reich E
    J Exp Med; 1974 May; 139(5):1317-28. PubMed ID: 4207624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteins of BrdU-dependent hamster cell lines as characterized by two-dimensional gel electrophoresis.
    Devine EA; Bick MD
    Differentiation; 1979; 12(3):157-66. PubMed ID: 467858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of retinoic acid effects on anchorage-dependent growth, anchorage-independent growth and fibrinolytic activity of neoplastic cells.
    Lotan R; Lotan D; Kadouri A
    Exp Cell Res; 1982 Sep; 141(1):79-86. PubMed ID: 6956516
    [No Abstract]   [Full Text] [Related]  

  • 29. Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.
    Silagi S
    In Vitro; 1971; 7(2):105-14. PubMed ID: 5170776
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of 5-bromodeoxyuridine (BUdR) on experimental metastasis.
    Zeidman I
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):827-35. PubMed ID: 4701271
    [No Abstract]   [Full Text] [Related]  

  • 31. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL; Horn D
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
    de Vries TJ; Kitson JL; Silvers WK; Mintz B
    Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between tumorigenicity and level of plasminogen activator in fibroblasts transformed by Rous sarcoma virus.
    Wolf BA; Goldberg AR
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4967-71. PubMed ID: 217007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor growth and metastases in malignant disease. A review.
    Kwaan HC
    J Med; 1988; 19(3-4):179-91. PubMed ID: 3141546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some effects of 5-bromodeoxyuridine on polyoma-transformed mouse cells.
    Grady LJ; North AB
    Exp Cell Res; 1974 Jul; 87(1):120-6. PubMed ID: 4366852
    [No Abstract]   [Full Text] [Related]  

  • 38. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
    Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
    Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenic effects of brief exposure to bromodeoxyuridine on mouse FM3A cells.
    Matsuoka K; Nomura K; Hoshino T
    Cell Tissue Kinet; 1990 Sep; 23(5):495-503. PubMed ID: 2245446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Natural inhibitors of fibrinolysis and their physiological importance].
    Pastorova VE
    Usp Fiziol Nauk; 1974; 5(4):80-95. PubMed ID: 4279526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.